Of note, treatment of N2a cells overexpressing a pro-aggregation form of Tau (TauRDΔK) with exosomes isolated from human CSF induces aggregation of Tau, although there is no significant difference in the seeding properties between AD- and healthy subject-derived exosomes [93]. The gene discussed is MAPT; the disease is Alzheimer disease.